Skip to main content
Equibles

SMNR · Semnur Pharmaceuticals, Inc. · Share Buybacks

Track SMNR — free

Use SMNR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SMNR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.45 -0.12 (-21.05%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 10, 2026
Market Cap
$137.90M
Shares
230.21M
Volume · Oct 2 3553 Avg daily vol (3M) 10.01K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended Cash Spent
2025-06-30 YTD $8,617,553
2024-12-31 $43,425,328
2023-12-31 $40,536,908
Key facts CIK 1913577 CUSIP 81686G105 Visit website Investor relations